Skip to main content
. 2022 Aug 26;65(17):11415–11432. doi: 10.1021/acs.jmedchem.2c00573

Table 2. IC50 (μM) Study for Anti-cancer Drugs against Colorectal Cancer (CRC), Ovarian Cancer (OC), and Chronic Lymphocytic Leukemia (CLL) Tumors72.

drug CRC OC CLL mononuclear cells
ACF 1.4 4.2 2.6 1.4
5-FU 755.2 562.8 658.2 429.8
irinotecan 89.6 75.3 29.3 25.4
oxaliplatin 26.1 10.9 7.6 2.9